PROCTER & GAMBLE HEALTH | TRIDENT LIFELINE | PROCTER & GAMBLE HEALTH/ TRIDENT LIFELINE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | - | - | View Chart |
P/BV | x | 10.6 | 4.2 | 253.8% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH TRIDENT LIFELINE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
TRIDENT LIFELINE Mar-23 |
PROCTER & GAMBLE HEALTH/ TRIDENT LIFELINE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 180 | 2,981.7% | |
Low | Rs | 3,883 | 103 | 3,779.1% | |
Sales per share (Unadj.) | Rs | 740.7 | 27.6 | 2,687.9% | |
Earnings per share (Unadj.) | Rs | 138.2 | 5.2 | 2,642.9% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 5.5 | 2,796.8% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 39.7 | 1,128.0% | |
Shares outstanding (eoy) | m | 16.60 | 11.50 | 144.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 5.1 | 121.7% | |
Avg P/E ratio | x | 33.5 | 27.0 | 123.8% | |
P/CF ratio (eoy) | x | 29.8 | 25.5 | 117.0% | |
Price / Book Value ratio | x | 10.3 | 3.6 | 290.0% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 1,625 | 4,722.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 13 | 16,119.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 317 | 3,879.9% | |
Other income | Rs m | 184 | 12 | 1,588.1% | |
Total revenues | Rs m | 12,480 | 329 | 3,799.1% | |
Gross profit | Rs m | 3,247 | 63 | 5,181.6% | |
Depreciation | Rs m | 281 | 4 | 7,698.6% | |
Interest | Rs m | 8 | 5 | 159.8% | |
Profit before tax | Rs m | 3,142 | 66 | 4,776.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 6 | 15,049.7% | |
Profit after tax | Rs m | 2,295 | 60 | 3,815.0% | |
Gross profit margin | % | 26.4 | 19.8 | 133.5% | |
Effective tax rate | % | 27.0 | 8.6 | 315.1% | |
Net profit margin | % | 18.7 | 19.0 | 98.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 489 | 2,396.6% | |
Current liabilities | Rs m | 6,791 | 113 | 6,022.9% | |
Net working cap to sales | % | 40.0 | 118.6 | 33.7% | |
Current ratio | x | 1.7 | 4.3 | 39.8% | |
Inventory Days | Days | 263 | 43 | 614.4% | |
Debtors Days | Days | 343 | 1,396 | 24.6% | |
Net fixed assets | Rs m | 10,617 | 94 | 11,264.6% | |
Share capital | Rs m | 166 | 115 | 144.4% | |
"Free" reserves | Rs m | 7,265 | 341 | 2,128.1% | |
Net worth | Rs m | 7,431 | 456 | 1,628.2% | |
Long term debt | Rs m | 0 | 22 | 0.0% | |
Total assets | Rs m | 22,330 | 587 | 3,807.0% | |
Interest coverage | x | 409.1 | 14.6 | 2,792.7% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.5 | 101.9% | |
Return on assets | % | 10.3 | 11.1 | 93.1% | |
Return on equity | % | 30.9 | 13.2 | 234.3% | |
Return on capital | % | 42.4 | 14.8 | 287.2% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 168 | 873.9% | |
Fx outflow | Rs m | 1,605 | 5 | 33,585.8% | |
Net fx | Rs m | -140 | 163 | -86.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -174 | -1,352.9% | |
From Investments | Rs m | -215 | -69 | 309.8% | |
From Financial Activity | Rs m | -985 | 380 | -259.1% | |
Net Cashflow | Rs m | 1,160 | 136 | 852.2% |
Indian Promoters | % | 0.0 | 66.4 | - | |
Foreign collaborators | % | 51.8 | 1.1 | 4,935.2% | |
Indian inst/Mut Fund | % | 20.0 | 6.0 | 331.7% | |
FIIs | % | 6.2 | 6.0 | 103.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 32.5 | 148.2% | |
Shareholders | 56,778 | 500 | 11,355.6% | ||
Pledged promoter(s) holding | % | 0.0 | 1.8 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | TRIDENT LIFELINE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -6.25% | 0.45% |
1-Month | -1.15% | 5.33% | 2.55% |
1-Year | 0.73% | 12.63% | 56.14% |
3-Year CAGR | -8.76% | 15.12% | 15.22% |
5-Year CAGR | 4.97% | 8.82% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the TRIDENT LIFELINE share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of TRIDENT LIFELINE the stake stands at 67.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of TRIDENT LIFELINE.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
TRIDENT LIFELINE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of TRIDENT LIFELINE.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.